Loss-of-function mutation in IKZF2 leads to immunodeficiency with dysregulated germinal center reactions and reduction of MAIT cells
Preprint
Abstract
The IKAROS family transcription factors regulate lymphocyte development. Loss-of-function variants in IKZF1 cause primary immunodeficiency, but IKAROS family members IKZF2 and IKZF3 have not yet been associated with immunodeficiency yet. Here, we describe a pedigree with a heterozygous truncating variant in IKZF2 , encoding the translational activator and repressor HELIOS which is highly expressed in regulatory T cells and effector T cells, particularly of the CD8 + T cell lineage. Protein-protein interaction analysis revealed that the variant abolished HELIOS dimerizations as well as binding to members of the Mi-2/NuRD chromatin remodeling complex. Patients carrying the IKZF2 variant presented with a combined immunodeficiency phenotype characterized by recurrent upper respiratory infections, thrush and mucosal ulcers, as well as chronic lymphadenopathy. With extensive immunophenotyping, functional assays, and transcriptional analysis we show that reduced HELIOS expression was associated with chronic T cell activation and increased production of pro-inflammatory cytokines both in effector and regulatory T cells. Lymph node histology from patients indicated dysregulated germinal center reactions. Moreover, affected individuals displayed profoundly reduced circulating MAIT cell numbers. In summary, we show that this novel loss-of-function variant in HELIOS leads to an immunodeficiency with signs of immune overactivation. One sentence summary: Truncating variant of HELIOS causes immunodeficiency with signs of immune overactivation.Keywords
All Related Versions
- Published version: Science Immunology, 6 (65), eabe3454.
This publication has 53 references indexed in Scilit:
- IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid DifferentiationCell Stem Cell, 2019
- Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiencyJournal of Clinical Investigation, 2018
- The making of a lymphocyte: the choice among disparate cell fates and the IKAROS enigmaGenes & Development, 2017
- Loss of B Cells in Patients with Heterozygous Mutations in IKAROSNew England Journal of Medicine, 2016
- Stable inhibitory activity of regulatory T cells requires the transcription factor HeliosScience, 2015
- Adult T‐cell leukemia cells are characterized by abnormalities of Helios expression that promote T cell growthCancer Science, 2013
- Helios Deficiency Has Minimal Impact on T Cell Development and functionThe Journal of Immunology, 2009
- Predominant Interaction of Both Ikaros and Helios with the NuRD Complex in Immature ThymocytesJournal of Biological Chemistry, 2007
- Ikaros, Aiolos and Helios: Transcription regulators and lymphoid malignanciesImmunology & Cell Biology, 2003
- Ikaros DNA-Binding Proteins Direct Formation of Chromatin Remodeling Complexes in LymphocytesImmunity, 1999